OFFIDANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 1.079
AS - Asia 775
EU - Europa 631
SA - Sud America 199
AF - Africa 62
OC - Oceania 1
Totale 2.747
Nazione #
US - Stati Uniti d'America 1.040
VN - Vietnam 210
IT - Italia 195
SG - Singapore 192
BR - Brasile 145
CN - Cina 137
RU - Federazione Russa 124
HK - Hong Kong 105
DE - Germania 67
FR - Francia 51
CI - Costa d'Avorio 32
FI - Finlandia 32
GB - Regno Unito 29
AR - Argentina 27
IN - India 25
IE - Irlanda 23
SE - Svezia 23
UA - Ucraina 19
JP - Giappone 17
TR - Turchia 17
CA - Canada 16
NL - Olanda 14
AT - Austria 13
MX - Messico 12
BD - Bangladesh 11
DK - Danimarca 9
EC - Ecuador 9
MA - Marocco 9
SA - Arabia Saudita 8
ZA - Sudafrica 8
ID - Indonesia 7
IQ - Iraq 7
UZ - Uzbekistan 7
ES - Italia 6
CO - Colombia 5
PK - Pakistan 5
PL - Polonia 5
VE - Venezuela 5
HU - Ungheria 4
KR - Corea 4
SN - Senegal 4
BE - Belgio 3
CR - Costa Rica 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
CH - Svizzera 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
Totale 2.747
Città #
Ashburn 271
Dallas 130
Singapore 110
Hong Kong 101
San Jose 98
Ho Chi Minh City 76
Hanoi 48
Boardman 42
The Dalles 34
Los Angeles 33
Abidjan 32
Munich 31
Council Bluffs 28
Chandler 26
Moscow 25
New York 25
Beijing 24
Dublin 23
Lauterbourg 23
São Paulo 22
Helsinki 20
Milan 20
Rome 19
Hefei 18
Frankfurt am Main 16
Santa Clara 16
Jacksonville 15
Fairfield 14
Denver 12
Wilmington 12
Da Nang 11
Orem 11
Turin 11
Buffalo 10
Seattle 10
Chennai 9
Nuremberg 9
Turku 9
Brooklyn 8
Houston 8
Tokyo 8
Amsterdam 7
Ancona 7
Guangzhou 7
Mexico City 7
Bari 6
Chicago 6
Tashkent 6
Woodbridge 6
Bologna 5
Cambridge 5
Falconara Marittima 5
Haiphong 5
Johannesburg 5
Lawrence 5
London 5
Montreal 5
North Charleston 5
Princeton 5
Atlanta 4
Brescia 4
Camden 4
Dakar 4
Hải Dương 4
Ninh Bình 4
Piscataway 4
Rio de Janeiro 4
Warsaw 4
Washington 4
Ankara 3
Ann Arbor 3
Baghdad 3
Biên Hòa 3
Boston 3
Brussels 3
Buenos Aires 3
Caracas 3
Curitiba 3
Guayaquil 3
Holstebro 3
Huế 3
Magnesia ad Sipylum 3
Manchester 3
Medellín 3
Miami 3
Mumbai 3
New Delhi 3
Pescara 3
Phoenix 3
Plano 3
Poplar 3
Quito 3
Quảng Ninh 3
San Mateo 3
Southwark 3
Thái Bình 3
Thái Nguyên 3
Toronto 3
Wuxi 3
Altamura 2
Totale 1.702
Nome #
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 158
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 144
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 138
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 133
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 125
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study 123
Current Main Topics in Multiple Myeloma 123
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 123
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES 122
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 114
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 111
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 108
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety 107
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 105
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 102
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 101
AL amyloidosis: an overview on diagnosis, staging system, and treatment 99
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy 97
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 97
Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences 96
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients 95
Long-Term Survival with Multiple Myeloma: An Italian Experience 95
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management 81
Sequential Bispecific Antibodies in Functional and Clinical High Risk Multiple Myeloma, Manifesting with Extramedullary Disease at Relapse: A Case Report 67
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 62
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience 53
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 50
Totale 2.829
Categoria #
all - tutte 10.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/202232 2 3 2 1 0 1 5 3 1 2 6 6
2022/202387 5 11 7 3 4 11 0 4 18 0 24 0
2023/2024182 15 5 8 11 22 18 4 5 9 7 23 55
2024/2025549 40 27 21 6 12 33 40 25 130 80 57 78
2025/20261.860 145 135 169 174 188 179 367 145 107 152 61 38
Totale 2.829